Analysis of chromosomal rearrangements has been highly successful in identifying genes involved in many congenital abnormalities including hearing loss. Herein, we report a subject, designated DGAP242, with congenital hearing loss (HL) and a de novo balanced translocation 46,XX,t(1;5)(q32;q15)dn. Using multiple next-generation sequencing techniques, we obtained high resolution of the breakpoints. This revealed disruption of the orphan receptor ESRRG on chromosome 1, which is differentially expressed in inner ear hair cells and has previously been implicated in HL, and disruption of KIAA0825 on chromosome 5. Given the translocation breakpoints and supporting literature, disruption of ESRRG is the most likely cause for DGAP242's phenotype and implicates ESRRG in a monogenic form of congenital HL, although a putative contributory role for KIAA0825 in the subject's disorder cannot be excluded. European Journal of Human Genetics (2016) 24, 1622-1626; doi:10.1038/ejhg.2016.64; published online 6 July 2016
INTRODUCTIONHearing loss (HL) is one of the most common birth defects, affecting over one in a thousand newborns. Over half of these cases can be attributed to a genetic etiology. 1 Chromosomal abnormalities have been implicated in several genetic forms of congenital HL including Down, Smith-Magenis and Branchio-Oto-Renal syndromes. 2 In cases of congenital HL accompanied with balanced chromosomal abnormalities (BCAs), high resolution of chromosomal breakpoints can reveal genes that have been disrupted, implicating them in auditory pathology. 3 By employing this strategy, the Developmental Genome Anatomy Project (DGAP, dgap.harvard.edu) has successfully resolved the genetic etiology of HL in several cases of BCAs. 4-6 Herein, we report the highresolution breakpoints from a de novo translocation discovered in a 6-year-old female with congenital bilateral sensorineural hearing loss (SNHL) accompanied with a developmental disorder of speech and language.